| Product Code: ETC9215833 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Parkinsons Disease Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Parkinsons Disease Market - Industry Life Cycle |
3.4 Serbia Parkinsons Disease Market - Porter's Five Forces |
3.5 Serbia Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Serbia Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Serbia Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Serbia Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Serbia Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Serbia Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about Parkinson's disease in Serbia |
4.2.2 Technological advancements in diagnosis and treatment options |
4.2.3 Growing elderly population in Serbia |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in remote areas of Serbia |
4.3.2 High treatment costs and limited reimbursement options |
4.3.3 Lack of trained healthcare professionals specializing in Parkinson's disease in Serbia |
5 Serbia Parkinsons Disease Market Trends |
6 Serbia Parkinsons Disease Market, By Types |
6.1 Serbia Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Serbia Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Serbia Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Serbia Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Serbia Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Serbia Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Serbia Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Serbia Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Serbia Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Serbia Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Serbia Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Serbia Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Serbia Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Serbia Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Serbia Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Serbia Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Serbia Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Serbia Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Serbia Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Serbia Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Serbia Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Serbia Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Serbia Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Serbia Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Serbia Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Serbia Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Serbia Parkinsons Disease Market Export to Major Countries |
7.2 Serbia Parkinsons Disease Market Imports from Major Countries |
8 Serbia Parkinsons Disease Market Key Performance Indicators |
8.1 Number of Parkinson's disease awareness campaigns conducted annually |
8.2 Adoption rate of new technologies for Parkinson's disease diagnosis and treatment |
8.3 Percentage increase in the number of geriatric patients seeking treatment for Parkinson's disease |
9 Serbia Parkinsons Disease Market - Opportunity Assessment |
9.1 Serbia Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Serbia Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Serbia Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Serbia Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Serbia Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Serbia Parkinsons Disease Market - Competitive Landscape |
10.1 Serbia Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Serbia Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here